pERSUASIVE - Crunchbase Company Profile & Funding

Q: When was the last funding round for pERSUASIVE?

pERSUASIVE closed its last funding round on obfuscated from a Grant round.

Overview

pERSUASIVE

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About pERSUASIVE

CB Rank

1037758

pERSUASIVE is developing an early detection of Ischemic heart disease (IHD).

Founded

obfuscation

Private

Grant

Amsterdam, Noord-Holland, The Netherlands

1-10

nlc.health/venture/persuasive/

Health Care

Health Diagnostics

Medical

Medical Device

Funding Rounds

Grant

OBF

obfuscation

Pre-Seed

OBF

obfuscation

Key People

Leo Timmers: Inventor
Egbert Smit: CEO

Details

Legal Name

Persuasive B.V.

Also Known As

Persuasive

Operating Status

Active

Company Type

For Profit

About the Company

Persuasive is developing a diagnostic test to distinguish stable angina (SA) from unstable angina (UA) and for the identification of low- versus high-risk patients, respectively, which has previously been lacking. A simple blood test that can identify the patients with SA from patients with UA will be a tremendous step forward.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Persuasive Blood Test for Early Detection of Ischemic Heart Disease

A blood test that detects stable angina by identifying an extracellular vesicle protein signature to distinguish cardiac from non-cardiac chest pain.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - pERSUASIVE	—	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - pERSUASIVE	—	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - pERSUASIVE	—	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - pERSUASIVE	—	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - pERSUASIVE	—	obfuscated obfuscation	—	Grant

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - pERSUASIVE	—	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - pERSUASIVE	—	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - pERSUASIVE	—	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - pERSUASIVE	—	obfuscated obfuscation	—	Grant
obfuscated obfuscation	Grant - pERSUASIVE	—	obfuscated obfuscation	—	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
NLC	Yes	Pre Seed Round - pERSUASIVE	—
NLC	Yes	Pre Seed Round - pERSUASIVE	—
NLC	Yes	Pre Seed Round - pERSUASIVE	—
NLC	Yes	Pre Seed Round - pERSUASIVE	—
NLC	Yes	Pre Seed Round - pERSUASIVE	—